Whereas there was no significant difference regarding survival between MPN/CMML, JAK2-mutated CMML, and JAK2-nonmutated CMML, respectively, all these cohorts had a significantly inferior survival as compared to PV without a CMML-like phenotype (Figure 3). The gene discussed is JAK2; the disease is myeloproliferative neoplasm.